Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China · Delayed Price · Currency is CNY 9.83
-0.15 (-1.50%)
Apr 28, 2026, 3:00 PM CST
SHA:600867 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,197 | -42.72 | 1,168 | 1,582 | 1,308 |
Depreciation & Amortization | 271.12 | 188.2 | 185.87 | 151.17 | 143.65 |
Other Amortization | 29.87 | 0.81 | - | - | - |
Loss (Gain) From Sale of Assets | 3.12 | -15.13 | -0 | -0.19 | -7.71 |
Asset Writedown & Restructuring Costs | 271.08 | 335.78 | 10.13 | 2.04 | 23.04 |
Loss (Gain) From Sale of Investments | -1,180 | -123.29 | -92.45 | -930.32 | -296.88 |
Provision & Write-off of Bad Debts | - | -15.59 | 20.12 | -7.41 | 2.26 |
Other Operating Activities | 18.99 | 51.07 | 11.93 | -6.65 | 10.31 |
Change in Accounts Receivable | 85.45 | 319.11 | -430.93 | 140.57 | -88.27 |
Change in Inventory | 20.37 | -48.51 | -55.53 | -124.65 | -3.41 |
Change in Accounts Payable | -100.33 | -90.21 | 36.99 | 52.93 | 93.84 |
Operating Cash Flow | 689.23 | 459.74 | 861.52 | 863.09 | 1,180 |
Operating Cash Flow Growth | 49.92% | -46.64% | -0.18% | -26.88% | -1.00% |
Capital Expenditures | -517.69 | -568.73 | -348.13 | -492.88 | -600.75 |
Sale of Property, Plant & Equipment | 1.2 | 66.36 | 0.42 | - | 20.37 |
Cash Acquisitions | - | 0.15 | - | - | - |
Investment in Securities | 1,260 | -100 | 2.5 | 817.06 | 544.82 |
Other Investing Activities | 41.92 | 33.29 | 23.22 | 19.82 | 23.79 |
Investing Cash Flow | 785.13 | -568.93 | -321.99 | 343.99 | -11.76 |
Long-Term Debt Issued | 473 | 840.25 | 314.03 | - | - |
Total Debt Issued | 473 | 840.25 | 314.03 | - | - |
Long-Term Debt Repaid | -648.9 | -447.03 | -40 | - | - |
Total Debt Repaid | -648.9 | -447.03 | -40 | - | - |
Net Debt Issued (Repaid) | -175.9 | 393.22 | 274.03 | - | - |
Issuance of Common Stock | 8.73 | 7.25 | - | - | - |
Repurchase of Common Stock | - | -300.28 | - | - | - |
Common Dividends Paid | -505.28 | -495.78 | -496.25 | -1,096 | -425.04 |
Other Financing Activities | 33.01 | -13.17 | -1.74 | -188.28 | -270.56 |
Financing Cash Flow | -639.44 | -408.76 | -223.95 | -1,284 | -695.6 |
Foreign Exchange Rate Adjustments | 0.07 | 0.34 | 0.57 | 0 | -0 |
Net Cash Flow | 834.98 | -517.61 | 316.14 | -76.98 | 473.01 |
Free Cash Flow | 171.53 | -108.99 | 513.4 | 370.21 | 579.62 |
Free Cash Flow Growth | - | - | 38.68% | -36.13% | -18.67% |
Free Cash Flow Margin | 5.82% | -5.42% | 16.69% | 13.32% | 17.74% |
Free Cash Flow Per Share | 0.09 | -0.05 | 0.26 | 0.18 | 0.28 |
Cash Interest Paid | - | 10.01 | 1.66 | - | - |
Cash Income Tax Paid | 414.03 | 166.17 | 219.83 | 284.18 | 217.64 |
Levered Free Cash Flow | 267.58 | -151.63 | 373.08 | 187.64 | 347.72 |
Unlevered Free Cash Flow | 267.58 | -142.64 | 376.31 | 187.81 | 347.72 |
Change in Working Capital | 77.45 | 80.61 | -441.92 | 72.56 | -2.56 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.